DrugFeb 27, 2019
Amerigen Pharmaceuticals Temozolomide Capsules, 5 mg recall — FDA D-0516-2019
Failed dissolution specifications
Class IIIFDA: TerminatedAmerigen Pharmaceuticals Inc.
Recall history in this database
Classification mix: Class III: 4.
DrugJan 2, 2019
Amerigen Pharmaceuticals Temozolomide Capsules, 180 mg recall — FDA D-0345-2019
Failed Dissolution Specifications
Class IIIFDA: TerminatedAmerigen Pharmaceuticals Inc.
DrugJan 2, 2019
Amerigen Pharmaceuticals Temozolomide Capsules, 20 mg recall — FDA D-0344-2019
Failed Dissolution Specifications
Class IIIFDA: TerminatedAmerigen Pharmaceuticals Inc.
DrugOct 24, 2018
Amerigen Pharmaceuticals Temozolomide capsules, 20 mg recall — FDA D-0249-2019
Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.
Class IIIFDA: TerminatedAmerigen Pharmaceuticals Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Amerigen Pharmaceuticals Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.